Stock screener

DYAI

Conviction 20HealthcareScan · Thu, Jun 25, 2026
DYAI$0.7410+1.37%
ResistanceSupportVol 14
63 bars
Vol MA14 277.15K
Mar 26Apr 14May 1May 19Jun 8Jun 25
DYADIC INTERNATIONAL INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.dyadic.com
Price0.7410
Change+1.37%
Gap+9.45%
Rel volume3.32×
Avg volume720.08K
Avg $ vol522.55K
SMA 200.7428
SMA 500.7654
SMA 2000.8948
Price vs 50-3.19%
Price vs 200-17.19%
MA stackbearish
50/200 cross
Supertrenddown · 0.8717
RSI (14)49
MACD hist0.00
MACD crossbull · 7d
Stoch %K / %D36 / 44
ADX (14)24
+DI / −DI20 / 14
RSI divergence
MACD divergence
ATR %+9.81%
ADR %9.95%
52w high1.30
52w low0.6754
From 52w high-43.00%
Above 52w low+9.71%
New 52w highNo
SqueezeOff
Bollinger width26.70%
%B0.49
Donchian pos36.11%
Donchian high0.8900
Donchian low0.6568
AVWAP (52w high)0.8559
vs AVWAP high-13.42%
AVWAP (52w low)0.7413
vs AVWAP low-0.04%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d3.32×
Avg vol (14d)277.15K
Avg vol (20d)720.08K
Avg $ vol (20d)522.55K
Market cap27M
RS 3m (vs SPY)-25.70%
RS 6m (vs SPY)-34.62%
RS line new highNo
Trend template0/8
Technical rank22.6
1 week-12.68%
1 month-1.85%
3 months-15.07%
6 months-25.89%
1 year-24.83%
YTD-21.16%
P/E-3.67
P/B-66.22
P/S8.74
P/FCF
EPS-0.2300
Div yield
ROE
ROA-94.30%
Debt/Eq
Current2.42
EV/EBITDA
Gross margin
Net margin-238.31%
Rev growth-11.59%
EPS growth-26.78%
Price target
Target upside
Analyst rating
Institutional
Ent. value22.75M
Revenue1.11M
Net income-1.95M
Gross profit
Free cash flow
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out36.44M
Employees5
ListedFri, Nov 5, 2004
Free float26.98M
Float %74.0%
Short interest622.47K
Days to cover0.6d
Short volume54.3%
Squeeze score32 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction20 / 100
Pattern quality
Tech rank22.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance0.8600
Support0.6634
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DYAI

All disclosures →
No recent disclosed trades by Congress in DYAI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DYAI

No recent insider (Form 4) filings in DYAI. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DYAI · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.